• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型肿瘤相关巨噬细胞治疗靶点的开发与转化。

Development and translation of novel therapeutics targeting tumor-associated macrophages.

机构信息

Department of Medicine, University of Wisconsin-Madison, Madison, WI; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI.

Department of Medicine, University of Wisconsin-Madison, Madison, WI; Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI.

出版信息

Urol Oncol. 2019 Aug;37(8):556-562. doi: 10.1016/j.urolonc.2018.10.010. Epub 2018 Nov 17.

DOI:10.1016/j.urolonc.2018.10.010
PMID:30458979
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6525088/
Abstract

Tumor-associated macrophages (TAMs) regulate an array of tumor functions and have critical roles in both the progression and the eradication of cancer. Numerous therapies targeting TAMs are under development in cancer and many have demonstrated success at the preclinical and clinical levels. Most of these therapies fall within 3 main categories: systemic depletion of TAMs, inhibition of TAM recruitment and polarization, and promoting the antitumor functions of TAMs. In this article, the rationale behind these various therapies and approaches is reviewed along with supporting preclinical and clinical data.

摘要

肿瘤相关巨噬细胞(TAMs)调节一系列肿瘤功能,在癌症的进展和消除中具有关键作用。目前有许多针对 TAMs 的治疗方法正在癌症领域开发中,其中许多在临床前和临床水平都取得了成功。这些疗法大多属于以下 3 种主要类型:全身性耗尽 TAMs、抑制 TAM 募集和极化,以及促进 TAMs 的抗肿瘤功能。本文回顾了这些不同疗法和方法的原理,以及支持它们的临床前和临床数据。

相似文献

1
Development and translation of novel therapeutics targeting tumor-associated macrophages.新型肿瘤相关巨噬细胞治疗靶点的开发与转化。
Urol Oncol. 2019 Aug;37(8):556-562. doi: 10.1016/j.urolonc.2018.10.010. Epub 2018 Nov 17.
2
Targeting tumor-associated macrophages for cancer immunotherapy.针对肿瘤相关巨噬细胞的癌症免疫治疗。
Int Rev Cell Mol Biol. 2022;368:61-108. doi: 10.1016/bs.ircmb.2022.02.002. Epub 2022 Apr 27.
3
Progress in Tumor-Associated Macrophages: From Bench to Bedside.肿瘤相关巨噬细胞的研究进展:从 bench 到 bedside。 (注:bench 指实验室研究阶段,bedside 指临床应用阶段,这里直接保留英文以体现专业性和术语性)
Adv Biosyst. 2019 Feb;3(2):e1800232. doi: 10.1002/adbi.201800232. Epub 2018 Nov 13.
4
The role of macrophage in regulating tumour microenvironment and the strategies for reprogramming tumour-associated macrophages in antitumour therapy.巨噬细胞在调节肿瘤微环境中的作用及重编程肿瘤相关巨噬细胞在抗肿瘤治疗中的策略。
Eur J Cell Biol. 2021 Mar;100(2):151153. doi: 10.1016/j.ejcb.2021.151153. Epub 2021 Jan 13.
5
Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing.癌症免疫疗法:通过基因沉默靶向肿瘤相关巨噬细胞。
Methods Mol Biol. 2020;2115:289-325. doi: 10.1007/978-1-0716-0290-4_17.
6
Progress in tumor-associated macrophage (TAM)-targeted therapeutics.肿瘤相关巨噬细胞(TAM)靶向治疗的进展
Adv Drug Deliv Rev. 2017 May 15;114:206-221. doi: 10.1016/j.addr.2017.04.010. Epub 2017 Apr 25.
7
The role of tumor-associated macrophage in breast cancer biology.肿瘤相关巨噬细胞在乳腺癌生物学中的作用。
Histol Histopathol. 2018 Feb;33(2):133-145. doi: 10.14670/HH-11-916. Epub 2017 Jul 6.
8
Tumor-associated macrophages: role in cancer development and therapeutic implications.肿瘤相关巨噬细胞:在癌症发展中的作用及治疗意义。
Cell Oncol (Dordr). 2019 Oct;42(5):591-608. doi: 10.1007/s13402-019-00453-z. Epub 2019 May 29.
9
Tumor-Associated Macrophages as Target for Antitumor Therapy.肿瘤相关巨噬细胞作为抗肿瘤治疗的靶点。
Arch Immunol Ther Exp (Warsz). 2018 Apr;66(2):97-111. doi: 10.1007/s00005-017-0480-8. Epub 2017 Jun 28.
10
Tailoring Nanomaterials for Targeting Tumor-Associated Macrophages.为靶向肿瘤相关巨噬细胞而定制纳米材料。
Adv Mater. 2019 May;31(19):e1808303. doi: 10.1002/adma.201808303. Epub 2019 Mar 18.

引用本文的文献

1
drives the polarization of macrophages by regulating the RhoA-MAPK signaling pathway and thus affects liver fibrosis.通过调节 RhoA-MAPK 信号通路来驱动巨噬细胞的极化,从而影响肝纤维化。
Bioengineered. 2022 Apr;13(4):8747-8758. doi: 10.1080/21655979.2022.2056690.
2
Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting.前列腺癌研究:下一代;2019 年科菲-霍尔顿前列腺癌学会会议报告。
Prostate. 2020 Feb;80(2):113-132. doi: 10.1002/pros.23934. Epub 2019 Dec 11.
3
Nanoparticles Targeting Macrophages as Potential Clinical Therapeutic Agents Against Cancer and Inflammation.纳米颗粒靶向巨噬细胞作为治疗癌症和炎症的潜在临床治疗剂。
Front Immunol. 2019 Aug 21;10:1998. doi: 10.3389/fimmu.2019.01998. eCollection 2019.
4
Immune modulatory functions of EZH2 in the tumor microenvironment: implications in cancer immunotherapy.EZH2在肿瘤微环境中的免疫调节功能:对癌症免疫治疗的启示
Am J Clin Exp Urol. 2019 Apr 25;7(2):85-91. eCollection 2019.

本文引用的文献

1
Tumour-associated macrophages as treatment targets in oncology.肿瘤相关巨噬细胞作为肿瘤治疗的靶点。
Nat Rev Clin Oncol. 2017 Jul;14(7):399-416. doi: 10.1038/nrclinonc.2016.217. Epub 2017 Jan 24.
2
Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial.在临界可切除和局部晚期胰腺癌患者中,使用CCR2抑制剂联合FOLFIRINOX靶向肿瘤相关巨噬细胞:一项单中心、开放标签、剂量探索、非随机的1b期试验。
Lancet Oncol. 2016 May;17(5):651-62. doi: 10.1016/S1470-2045(16)00078-4. Epub 2016 Apr 4.
3
Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization.集落刺激因子1受体抑制通过改变髓样细胞募集和极化来延迟胶质母细胞瘤放疗后的复发。
Neuro Oncol. 2016 Jun;18(6):797-806. doi: 10.1093/neuonc/nov272. Epub 2015 Nov 3.
4
Secreted Factors from Colorectal and Prostate Cancer Cells Skew the Immune Response in Opposite Directions.来自结肠直肠癌和前列腺癌细胞的分泌因子使免疫反应向相反方向倾斜。
Sci Rep. 2015 Oct 27;5:15651. doi: 10.1038/srep15651.
5
Monocyte-derived macrophage assisted breast cancer cell invasion as a personalized, predictive metric to score metastatic risk.单核细胞衍生的巨噬细胞辅助乳腺癌细胞侵袭,作为一种个性化的预测指标来评估转移风险。
Sci Rep. 2015 Sep 9;5:13855. doi: 10.1038/srep13855.
6
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.结构导向的 CSF1R 激酶阻断在腱鞘巨细胞瘤中的应用。
N Engl J Med. 2015 Jul 30;373(5):428-37. doi: 10.1056/NEJMoa1411366.
7
CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.靶向CSF1受体治疗前列腺癌可逆转巨噬细胞介导的对雄激素阻断疗法的耐药性。
Cancer Res. 2015 Mar 15;75(6):950-62. doi: 10.1158/0008-5472.CAN-14-0992. Epub 2015 Mar 3.
8
Emodin suppresses pulmonary metastasis of breast cancer accompanied with decreased macrophage recruitment and M2 polarization in the lungs.大黄素抑制乳腺癌的肺转移,同时减少肺内巨噬细胞募集和M2极化。
Breast Cancer Res Treat. 2014 Nov;148(2):291-302. doi: 10.1007/s10549-014-3164-7. Epub 2014 Oct 14.
9
Tumor-associated macrophages as major players in the tumor microenvironment.肿瘤相关巨噬细胞作为肿瘤微环境中的主要参与者。
Cancers (Basel). 2014 Aug 13;6(3):1670-90. doi: 10.3390/cancers6031670.
10
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.在胰腺癌模型中,CSF1/CSF1R阻断可重编程肿瘤浸润巨噬细胞并改善对T细胞检查点免疫疗法的反应。
Cancer Res. 2014 Sep 15;74(18):5057-69. doi: 10.1158/0008-5472.CAN-13-3723. Epub 2014 Jul 31.